Delivery Order SPE2DB22D1052-SPE2DB25FU7WP

Award Date 10/28/24
Potential Completion Date 10/29/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB22D2006|SPE2DB24FW0XP, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $9,854.38 firm fixed-price delivery order is for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of June 7, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award, with identification number SPE2DB20D2104|SPE2DB25FMBAD, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,131.21 firm fixed-price delivery order is for the supply of 4566177902 - JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of October 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays...
This federal contract award, with ID SPE2DB20D2014|SPE2DB25FA27Q, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $31,056.59 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award, ID SPE2DB22D1106|SPE2DB25FDUV5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $11,275.27 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award, with the ID SPE2DB22D1017|SPE2DB24FF4AQ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $7,869.40 firm fixed-price delivery order is for the supply of 4563926286 - JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 12, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to...
This federal contract award, valued at $42,839.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, with a completion date of December 10, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside used. Amerisourcebergen Drug Corp is the prime contractor, and...
This federal contract award, valued at $15,039.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, with a completion date of April 25, 2024. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award, valued at $16,188.71, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a completion date of December 22, 2022. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,133.60 firm fixed-price delivery order contract is for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
This federal contract award, valued at $35,980.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation...
  • SPE2DB22D1052
    Indefinite Delivery Contract
  • SPE2DB22D1052-SPE2DB25FU7WP
    Delivery Order

This federal contract award, with the ID SPE2DB22D1052|SPE2DB25FU7WP, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $10,704.62 firm-fixed-price contract is for the delivery of 4566250982 JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of October 29, 2024.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with any set-aside requirements, indicating open competition.

Generated 5/20/25, 2:25 PM